FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4206610800> ?p ?o ?g. }

• W4206610800 endingPage "S231" @default.
• W4206610800 startingPage "S231" @default.
• W4206610800 abstract "Costs associated with acute myeloid leukemia (AML) present a considerable economic burden, and the impact of AML on patients’ health-related quality of life (HRQoL) may be substantial. However, the holistic economic and humanistic burdens of AML are not well understood. We conduct a comprehensive review of studies relating to cost-effectiveness/cost-utility and HRQoL for adult transplant-ineligible patients with AML receiving intensive induction chemotherapy. SLRs adhering to PRISMA guidelines were performed. A systematic search of MEDLINEâ, EMBASE, NHS EED, and Cochrane Central Register of Controlled Trials from 2005 to 2020 was conducted. A supplementary search of relevant congress abstracts (2018 and 2019) and health technology assessments (HTAs) was also conducted. Two reviewers independently screened study records, assessed study quality, and extracted data. The economic SLR identified 15 records (14 distinct analyses) that met inclusion criteria: 5 publications, 8 abstracts, and 2 HTA reports. A variety of therapies spanning all treatment phases were evaluated and included midostaurin (induction/consolidation/maintenance; n=11), CPX-351 (induction; n=2), gemtuzumab ozogamicin (induction/consolidation; n=1), and high-dose arabinoside/daunorubicin (consolidation; n=1). No studies were identified that evaluated the cost-effectiveness of maintenance therapy specifically. Across studies, cost-effectiveness was estimated using partitioned survival models (n=12) and state-transition models (n=1). The health-utility SLR identified 18 studies: 8 reported utility values by health state, 10 reported disease-specific HRQoL. The 8 studies reporting health utility values by health state included 4 utility elicitation studies and four economic evaluations. Assessments in the 10 disease-specific HRQoL studies included EORTC QLQ-C30 (n=6), FACT-Fatigue (6), FACT-Leukemia (3), and FACT-General (1). No maintenance-specific utility studies, and no studies reporting EQ-5D, were identified. Future studies are warranted, as there is a paucity of studies, particularly of maintenance therapies, evaluating the cost-effectiveness and health utilities associated with transplant-ineligible patients with AML receiving intensive induction chemotherapy." @default.
• W4206610800 created "2022-01-25" @default.
• W4206610800 creator A5001617887 @default.
• W4206610800 creator A5024264093 @default.
• W4206610800 creator A5050742399 @default.
• W4206610800 creator A5051510246 @default.
• W4206610800 date "2022-01-01" @default.
• W4206610800 modified "2023-09-27" @default.
• W4206610800 title "POSB364 Systematic Literature Reviews (SLRS) of Economic Evaluations and Health Utility Studies of AML Treatments for Adults Receiving High Intensity Induction Therapy, with or without Maintenance Therapy" @default.
• W4206610800 doi "https://doi.org/10.1016/j.jval.2021.11.1131" @default.
• W4206610800 hasPublicationYear "2022" @default.
• W4206610800 type Work @default.
• W4206610800 citedByCount "0" @default.
• W4206610800 crossrefType "journal-article" @default.
• W4206610800 hasAuthorship W4206610800A5001617887 @default.
• W4206610800 hasAuthorship W4206610800A5024264093 @default.
• W4206610800 hasAuthorship W4206610800A5050742399 @default.
• W4206610800 hasAuthorship W4206610800A5051510246 @default.
• W4206610800 hasBestOaLocation W42066108001 @default.
• W4206610800 hasConcept C10205521 @default.
• W4206610800 hasConcept C112930515 @default.
• W4206610800 hasConcept C126322002 @default.
• W4206610800 hasConcept C176290653 @default.
• W4206610800 hasConcept C17744445 @default.
• W4206610800 hasConcept C177713679 @default.
• W4206610800 hasConcept C189708586 @default.
• W4206610800 hasConcept C199539241 @default.
• W4206610800 hasConcept C2776611710 @default.
• W4206610800 hasConcept C2776694085 @default.
• W4206610800 hasConcept C2778283404 @default.
• W4206610800 hasConcept C2778623314 @default.
• W4206610800 hasConcept C2779473830 @default.
• W4206610800 hasConcept C28328180 @default.
• W4206610800 hasConcept C3019080777 @default.
• W4206610800 hasConcept C54355233 @default.
• W4206610800 hasConcept C64332521 @default.
• W4206610800 hasConcept C71924100 @default.
• W4206610800 hasConcept C86803240 @default.
• W4206610800 hasConceptScore W4206610800C10205521 @default.
• W4206610800 hasConceptScore W4206610800C112930515 @default.
• W4206610800 hasConceptScore W4206610800C126322002 @default.
• W4206610800 hasConceptScore W4206610800C176290653 @default.
• W4206610800 hasConceptScore W4206610800C17744445 @default.
• W4206610800 hasConceptScore W4206610800C177713679 @default.
• W4206610800 hasConceptScore W4206610800C189708586 @default.
• W4206610800 hasConceptScore W4206610800C199539241 @default.
• W4206610800 hasConceptScore W4206610800C2776611710 @default.
• W4206610800 hasConceptScore W4206610800C2776694085 @default.
• W4206610800 hasConceptScore W4206610800C2778283404 @default.
• W4206610800 hasConceptScore W4206610800C2778623314 @default.
• W4206610800 hasConceptScore W4206610800C2779473830 @default.
• W4206610800 hasConceptScore W4206610800C28328180 @default.
• W4206610800 hasConceptScore W4206610800C3019080777 @default.
• W4206610800 hasConceptScore W4206610800C54355233 @default.
• W4206610800 hasConceptScore W4206610800C64332521 @default.
• W4206610800 hasConceptScore W4206610800C71924100 @default.
• W4206610800 hasConceptScore W4206610800C86803240 @default.
• W4206610800 hasIssue "1" @default.
• W4206610800 hasLocation W42066108001 @default.
• W4206610800 hasOpenAccess W4206610800 @default.
• W4206610800 hasPrimaryLocation W42066108001 @default.
• W4206610800 hasRelatedWork W1488603340 @default.
• W4206610800 hasRelatedWork W1727233918 @default.
• W4206610800 hasRelatedWork W1841572063 @default.
• W4206610800 hasRelatedWork W2016006997 @default.
• W4206610800 hasRelatedWork W2085369334 @default.
• W4206610800 hasRelatedWork W2109610344 @default.
• W4206610800 hasRelatedWork W2329380270 @default.
• W4206610800 hasRelatedWork W2755966470 @default.
• W4206610800 hasRelatedWork W2955383188 @default.
• W4206610800 hasRelatedWork W3206671077 @default.
• W4206610800 hasVolume "25" @default.
• W4206610800 isParatext "false" @default.
• W4206610800 isRetracted "false" @default.
• W4206610800 workType "article" @default.